Nathan E Botts / Tuesday, October 3, 2023 / Categories: Mental Health Depression: The Case for Ketamine Depression: The Case for KetamineKetamine. For some people with treatment-resistant depression, this experimental therapy proved to be more than just life-changing—it was lifesaving. But how did a drug once used as a battlefield anesthetic evolve into esketamine, a treatment for major depressive illnesses? In this episode, we talk with Dr. Carlos Zarate Jr., who helped lay the groundwork for esketamine for treatment-resistant depression. We learn the history behind the development of esketamine, how it can help with depression, and what the future holds for this innovative line of clinical research.Link to original article Previous Article Pharmacy-Centered HIV Research Meeting Day 1 Next Article Real-World Opportunities & Challenges: Using NIMH's RDoC Framework in Global Mental Health Research Print 67 Rate this article: No rating 0Upvote 0Downvote Leave a comment Name: Please enter a name. Email: Please enter an email address. Please enter a valid email address. Comment: Please enter comment. Add comment